• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• Twitter
• Newsletter

Advertisement

Product › Details

pharmaceutical

Record changed: 2021-09-23

Advertisement

More documents for pharmaceutical

• [1] F-Star Therapeutics Ltd.. (10/20/21). "Press Release: F-star Therapeutics Announces License Agreement with Janssen to Develop and Commercialize Multiple Next Generation Bispecific Antibody Therapeutics". Cambridge & Cambridge, MA....
• [2] InflaRx N.V.. (10/19/21). "Press Release: InflaRx Awarded up to EUR 43.7 Million (~USD 50.7 Million) Grant by German Government to Advance the Development of Vilobelimab for Treatment of Severe COVID-19". Jena....
• [3] Immunocore Holdings plc. (10/18/21). "Press Release: Immunocore and Medison Pharma Partner for Future Commercialization of Tebentafusp in Canada, Central Eastern Europe, and Israel". Cambridge & Boston, MA....
• [4] Valneva S.E.. (10/18/21). "Press Release: Valneva Reports Positive Phase 3 Results for Inactivated, Adjuvanted COVID-19 Vaccine Candidate VLA2001". Saint-Herblain....
• [5] Silence Therapeutics plc. (10/15/21). "Press Release: Silence Therapeutics and Hansoh Pharma Announce Collaboration to Develop Therapeutics Leveraging Silence’s mRNAi GOLD™ Platform". London & Shanghai....
• [6] MaaT Pharma. (10/15/21). "Press Release: MaaT Pharma Launches Its Initial Public Offering on the Regulated Market of Euronext in Paris [ Not for US, CA, AU, JP or RK ]". Lyon....
• [7] Alto Neuroscience. (10/14/21). "Press Release: Alto Neuroscience Emerges with Largest Clinical-Stage Precision Psychiatry Pipeline and $40 Million in Financing". Los Altos, CA....
• [8] Rectify Pharmaceuticals, Inc.. (10/14/21). "Press Release: Rectify Pharmaceuticals Launches with $100 Million Series A Financing from Atlas Venture, Omega Funds, Forbion, and Longwood Fund". Cambridge, MA....
• [9] H. Lundbeck A/S. (10/14/21). "Press Release: Lundbeck Receives Exclusive Rights to APB-A1, an Innovative Phase I-ready Bio-therapeutic for the Treatment of Neuroimmune Diseases from AprilBio"....
• [10] Abalos Therapeutics GmbH. (10/14/21). "Press Release: Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million". Düsseldorf....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.